The invention relates to the formation of novel in vivo combinatorial enzyme complexes for use in screening candidate drug agents for bioactivity.

 
Web www.patentalert.com

< Apparatus for the controllable modification of compound concentration in a tube

< Compositions and methods for the therapy and diagnosis of breast cancer

> Microspheres with sacrificial coatings for vaso-occlusive systems

> Membrane type serine protease 1 (MT-SP1) and uses thereof
~ 00223